Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-002405

Chief Executive Officer bought 15,000 shares at $0.69 ($10,409)

From the SEC's structured data for this filing

Trades in this filing

Climaco John M · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-04-12 Purchase : show line 1 in the form +15,000 $0.69 $10,409 45,010 D
Open-market purchases · 15,000 sh · avg $0.69 · $10,409
Loading xslF345X04/ownership.xml…